Evidence map›Paper›PMID 41532006›Full record

ArticleMediators of inflammation2026

MicroRNA-223/NE Signaling Pathway Inhibits Lipopolysaccharide-Induced Acute Lung Injury by Regulating Neutrophil Extracellular Traps.

Zhengpeng Zeng, Yuexiang Qin, Xue He, Zhaoxia Tan

Abstract read
In one paragraph

Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhengpeng ZengHealth Management Medicine Center, The Third Xiangya Hospital, Central South University, Changsha, China, csu.edu.cn.ORCID https://orcid.org/0009-0002-5172-2508
Yuexiang QinHealth Management Medicine Center, The Third Xiangya Hospital, Central South University, Changsha, China, csu.edu.cn.ORCID https://orcid.org/0000-0002-0837-4643
Xue HeHealth Management Medicine Center, The Third Xiangya Hospital, Central South University, Changsha, China, csu.edu.cn.ORCID https://orcid.org/0000-0002-2746-6308
Zhaoxia TanHealth Management Medicine Center, The Third Xiangya Hospital, Central South University, Changsha, China, csu.edu.cn.ORCID https://orcid.org/0009-0000-0443-586X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute lung injury (ALI) is characterized by significant neutrophil infiltration in the lungs, representing a life-threatening condition with diverse etiologies. However, the mechanisms regulating neutrophil-alveolar epithelial interactions and the pathophysiological roles of neutrophil infiltration in ALI remain incompletely understood. Methods: A dose of 20 mg/kg lipopolysaccharide (LPS) was intratracheally instilled to induce ALI models in 10-week-old male microRNA-223 knockout mice (miR-223 Results: WB experiments showed an increase in NETs-related proteins MPO and H3Cit in the lungs of WT ALI mice, with significantly enhanced expression in miR-223 Conclusion: This study reveals that the miR-223/NE axis critically regulates NETs formation, modulating neutrophil inflammatory infiltration and neutrophil-epithelial interactions to exacerbate ALI. These findings provide potential therapeutic targets for ALI.

Indexed as

Acute Lung InjuryExtracellular TrapsLeukocyte ElastaseLipopolysaccharidesMicroRNAsNeutrophilsAnimalsHumansInterleukin-1betaInterleukin-6MaleMiceMice, Inbred C57BLMice, KnockoutSignal TransductionSulfonamidesInterleukin-1betaInterleukin-6Leukocyte ElastaseLipopolysaccharidesMicroRNAsMIRN223 microRNA, mouseSulfonamidesTumor Necrosis Factor-alpha

Identifiers

PMID41532006
PMCPMC12794271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.